OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Pecora Discusses Value-Based Healthcare

March 22nd 2011

Andrew L. Pecora, MD, Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center, discusses his thoughts on a value-based healthcare system.

Dr. Kris on Caring for Elderly Lung Cancer Patients

March 22nd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering on Caring for Elderly Lung Cancer Patients

Dr. Kris Discusses EGFR Mutation Testing

March 21st 2011

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses EGFR Mutation Testing

Dr. Alter on Trials and Ongoing Research in Kidney Cancer

March 21st 2011

Robert S. Alter, M.D. Co-chief, Urologic Oncology, John Theurer Cancer Center, on major trials and ongoing research in kidney cancer, in the spring of 2011.

Dr. Pearlstone on Ongoing Research in Breast Cancer

March 16th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center, on important research taking place in the field of breast oncology.

Dr. Jabbour on Front-Line Treatments for CML

March 15th 2011

Elias Jabbour, MD, Assistant Professor, Dept. of Leukemia, The University of Texas MD Anderson Cancer Center, discusses front-line treatments for CML, at the 2010 ASCO Annual Meeting.

Dr. Jabbour on Second-Generation TKIs in CML

March 15th 2011

Elias Jabbour, MD, Assistant Professor, Dept. of Leukemia, The University of Texas MD Anderson Cancer Center, on second-generation TKIs for patients with CML, a cancer that starts inside bone marrow.

Vandetanib Advantages in Medullary Thyroid Cancer

March 15th 2011

Dr. Langmuir on Vandetanib in Medullary Thyroid Cancer

March 15th 2011

Dr. Langmuir Discusses Vandetanib Clinical Trials

March 15th 2011

eter Langmuir, MD, Executive Director, Medical Science AstraZeneca, discusses the vandetanib clinical trials.

Dr. Pecora on his Personal Involvement in Research

March 15th 2011

Andrew L. Pecora, M.D., F.A.C.P., C.P.E. Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center, on his personal involvement in research.

Dr. Berenson on the Study of Zometa in Multiple Myeloma

March 15th 2011

James R. Berenson, MD, Medical & Scientific Director; Institute for Myeloma & Bone Cancer Research, on a study of zoledronic acid (Zometa) in patients with multiple myeloma.

Dr. Tripathy on Bone Health in Breast Cancer Patients

March 15th 2011

Debu Tripathy, MD, Co-leader Women's Breast Cancer Program at USC/Norris Comprehensive Cancer Center, on bone health considerations for patients with breast cancer.

Dr. Tripathy Discusses Bisphosphonate Studies

March 15th 2011

Debu Tripathy, MD, Co-leader Women’s Breast Cancer Program at USC/Norris Comprehensive Cancer Center, discusses clinical research and studies looking at the use of bisphosphonate for women with breast cancer.

Dr. Molina on Information for the Public on Kidney Cancer

March 14th 2011

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York, shares information that she feels the public should know about kidney cancer.

Dr. Pearlstone on Biomarker Testing in the Community

March 14th 2011

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Biomarker Testing in the Community Setting

Dr. Siegel on the Cost of Cancer Care

March 14th 2011

David S. Siegel, MD, PhD, Chief, Multiple Myeloma at John Theurer Cancer Center, on the escalating costs associated with cancer car

Dr. Alter on Kidney Injury in Relation to Patient Recovery

March 14th 2011

Dr. Robert Alter on ASCO GU-Kidney Cancer Findings

March 14th 2011

Dr. Molina on Her Recent Presentation at ASCO GU 2011

March 14th 2011

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York, talks about her presentation at 2011 ASCO Genitourinary conference.